Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure

doi:10.4254/wjh.117018

Home
English
- English
- 简体中文
Sign In
Help Desk
Journals
Login

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Featured Articles

Journals

Submit a Manuscript

Home / Archive / Volume 18, Issue 6

This Article

Abstract
Core Tip
Full Article (XML)
Full Article (HTML)
Audio
Citation of This Article

CrossRef
Google Scholar

Similar Articles (120)
Timeline of Article Publication (0)
Reference Citation Analysis (0)

(1)

(0)

(1)

Peer-Review Report of This Article

Answering Reviewers (PDF)
Peer-Review Report (PDF)

CrossCheck and Google Search of This Article

CrossCheck Report (PDF)

Academic Rules and Norms of This Article

Conflict-of-Interest Statement (PDF)
Copyright Assignment (PDF)

Citation of this article

El Tawil AI, Ivantes CAP. Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure. World J Hepatol 2026; 18(6): 117018 [DOI: 10.4254/wjh.117018]

Corresponding Author of This Article

Abdo Imad El Tawil, Principal Investigator, Researcher, Department of Medical Research, Faculdade Evangélica Mackenzie do Paraná, Rua Padre Anchieta 2770, Curitiba 80730-000, Paraná, Brazil. abdoieltawil@gmail.com

Research Domain of This Article

Gastroenterology & Hepatology

Article-Type of This Article

letter

Open-Access Policy of This Article

This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Times Cited Counts in Google of This Article

Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Share the Article

El Tawil AI, Ivantes CAP. Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure. World J Hepatol 2026; 18(6): 117018 [DOI: 10.4254/wjh.117018]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

- Full Article (XML)

Invalid Article

Reference Citation Analysis PubMed PubMed Central

Preprints.org Scopus Google Scholar